Protagenic Therapeutics, Inc.\new reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 March
Protagenic Therapeutics, Inc.\new has filed 705 SEC EDGAR filings since 22 Oct 1996

SEC filing history

Showing 26-50 of 448 matching filings.

Per page
25
Current page
2
424B5 File 333-280244

424B5

Filing date
24 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
24 Oct 2025
Reporting date
15 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-48089

SCHEDULE 13G/A filing

Filing date
25 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-12555

NT 10-Q

Filing date
14 Aug 2025
Reporting date
30 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-48089

SCHEDULE 13G filing

Filing date
08 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-12555

DEFA14A

Filing date
19 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-12555

10-K filing

Filing date
31 Mar 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
DEF 14A File 001-12555

DEF 14A filing

Filing date
10 Mar 2025
Reporting date
07 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-12555

PRE 14A filing

Filing date
27 Feb 2025
Reporting date
26 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .